http://orcid.org/0000-0003-4589-1428
References
- Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7(4):299–309.
- British Medical Journal Publishing G. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2002;325(7376):1363–1364.
- Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245–1251.
- Hacke W. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017.
- Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial. JAMA. 1999;282(21):2019–2026.
- Clark WM, Albers GW, Madden KP, et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part a (A0276g) results of a double-blind, placebo-controlled, multicenter study. Stroke. 2000;31(4):811–816.
- National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1588.
- Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110.
- Khatri P, Conaway MR, Johnston KC, et al. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke. 2012;43(2):560–562.
- Fischer U, Baumgartner A, Arnold M, et al. What is a minor stroke? Stroke. 2010;41(4):661–666.
- Meyer W, Lavados PM, Olavarria V. Thrombolysis in mild stroke. Outcomes from the Recca registry. Eur Stroke J. 2016;1(1):AS08–AS041.
- Mazya M, Cooray C, Lees KR, et al. Mild stroke due to large artery occlusion. when is IV thrombolysis not enough? Results from the SITS-ISTR registry. Eur Stroke J. 2017;2(1):487–488.
- Laurencin C, Philippeau F, Blanc-Lasserre K, et al. Thrombolysis for acute minor stroke: outcome and barriers to management. Results from the RESUVAL stroke network. Cerebrovasc Dis. 2015;40(1–2):3–9.
- Förster A, Griebe M, Gass A. Intravenous thrombolysis in minor stroke. Cerebrovasc Dis. 2011;31:270.
- Mittal M, Rymer M, Lai SML. Intravenous rt-PA and outcome after a mild stroke. Stroke. 2011;42(3):e264.
- Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3–4.5 h after an acute stroke—an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866–874.
- Khatri P, Kleindorfer DO, Devlin T, et al. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial. JAMA. 2018;320(2):156–166.
- Romano JG, Smith EE, Liang L, et al. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. JAMA Neurol. 2015;72(4):423–431.
- Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11–19.
- Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215–225.
- 21. Chinese Society of Neurology, C.S.S. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018. Chin J Neurol. 2018;51(9):665–682.
- Chinese Society of Neurology, C.S.S. Chinese guidelines for the prevention of stroke in patients with ischemic stroke and transient ischemic attack 2014. Chin J Neurol. 2015;48(4):258–273.
- Ralph B, D'Agostino J. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281.
- Tan Y, Pan Y, Liu L, et al. One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry. Neurol Res. 2017;39(6):484–491.
- Park H-K, Kim BJ, Han M-K, et al. One-year outcomes after minor stroke or high-risk transient ischemic attack: Korean multicenter stroke registry analysis. Stroke. 2017;48(11):2991–2998.